Aortic Regurgitation is Associated with African American and Asian Race, Smoking, Renal Disease, and Numerous Autoimmune Diseases in Addition to Traditional Cardiovascular Risk Factors but Has lower Risk with Alcohol Intake

Overview

Journal Clin Res Cardiol

Specialty Cardiology & Vascular Diseases

Date 2024 Mar 13

PMID 38478089

Authors

Brandon Timmerman

Mehrtash Hashemzadeh

Mohammad Reza Movahed

Affiliations

Soon will be listed here.

Abstract

Background: Aortic regurgitation (AR) is associated with increasing age, rheumatic heart disease, and a bicuspid aortic valve, but its association with other comorbidities and race is less known. The purpose of this study was to investigate any association between AR and comorbid conditions in older adults above 40.

Method: The large Nationwide Inpatient Sample database was utilized for our study using uni- and multivariate analysis. Data were extracted from available ICD-10 codes for the years of 2016-2020.

Results: The NIS data included 112,982,565 patients. A total of 660,730 were found to have AR. AR was found to be associated with male gender (OR 1.15, CI 1.14-1.16, P < 0.001), smoking (OR 1.04, CI 1.02-1.05, P < 0.001), hypertension (OR 1.65, CI 1.62-1.68, P < 0.001), hyperlipidemia (OR 1.36, CI 1.34-1.37, P < 0.001), chronic kidney disease (OR 1.22, CI 1.21-1.24, P < 0.001), antiphospholipid antibody syndrome (OR 1.56, CI 1.33-1.83, P < 0.001), rheumatoid arthritis (OR 1.1, CI 1.06-1.14, P < 0.001), scleroderma (OR 1.49, CI 1.31-1.7, P < 0.001), systemic connective tissue disorders (OR 1.32, CI 1.25-1.4, P < 0.001), Raynaud's syndrome (OR 1.62, CI 1.47-1.77, P < 0.001), and systemic lupus erythematosus (OR 1.44, CI 1.34-1.54, P < 0.001) in add to known bicuspid aortic valve.

Conclusion: Using a very large database, we found new associations between AR and many comorbid conditions, including many inflammatory and chronic degenerative diseases in addition to the known risk factors.

References

Akinseye O, Pathak A, Ibebuogu U . Aortic Valve Regurgitation: A Comprehensive Review. Curr Probl Cardiol. 2017; 43(8):315-334. DOI: 10.1016/j.cpcardiol.2017.10.004. View

Iung B, Vahanian A . Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol. 2011; 8(3):162-72. DOI: 10.1038/nrcardio.2010.202. View

Dujardin K, Enriquez-Sarano M, Schaff H, Bailey K, Seward J, Tajik A . Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation. 1999; 99(14):1851-7. DOI: 10.1161/01.cir.99.14.1851. View

Yang L, Michelena H, Maleszewski J, Schaff H, Pellikka P . Contemporary Etiologies, Mechanisms, and Surgical Approaches in Pure Native Aortic Regurgitation. Mayo Clin Proc. 2019; 94(7):1158-1170. DOI: 10.1016/j.mayocp.2018.11.034. View

Evangelista A, Gallego P, Calvo-Iglesias F, Bermejo J, Robledo-Carmona J, Sanchez V . Anatomical and clinical predictors of valve dysfunction and aortic dilation in bicuspid aortic valve disease. Heart. 2017; 104(7):566-573. DOI: 10.1136/heartjnl-2017-311560. View

Singh J, Evans J, Levy D, Larson M, Freed L, FULLER D . Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999; 83(6):897-902. DOI: 10.1016/s0002-9149(98)01064-9. View

Stefano G, Fox K, Schluchter M, Hoit B . Prevalence of unsuspected and significant mitral and aortic regurgitation. J Am Soc Echocardiogr. 2007; 21(1):38-42. DOI: 10.1016/j.echo.2007.05.006. View

Hoshino N, Yamada A, Kawada Y, Hoshino M, Yamabe S, Takada K . Age-related etiologies of aortic regurgitation with moderate or greater severity and coronary cusp bending: evaluation using transesophageal echocardiography. J Med Ultrason (2001). 2022; 49(2):231-239. DOI: 10.1007/s10396-021-01177-0. View

Shimada S, Matsuura M, Yamaguchi T, Hama J . Analyzing the association between aortic regurgitation and atherosclerosis: is pulse pressure a cause of atherosclerosis?. Clin Exp Hypertens. 2018; 40(8):796-802. DOI: 10.1080/10641963.2018.1433195. View

10.

Li C, Xu S, Gotlieb A . The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops. Cardiovasc Pathol. 2012; 22(1):1-8. DOI: 10.1016/j.carpath.2012.06.005. View

11.

Palmieri V, Bella J, Arnett D, Oberman A, Kitzman D, Hopkins P . Associations of aortic and mitral regurgitation with body composition and myocardial energy expenditure in adults with hypertension: the Hypertension Genetic Epidemiology Network study. Am Heart J. 2003; 145(6):1071-7. DOI: 10.1016/S0002-8703(03)00099-1. View

12.

Gardin J, Constantine G, Davis K, Leung C, Reid C . Aortic valvular regurgitation: prevalence and clinical characteristics in a predominantly obese adult population not taking anorexigens. Echocardiography. 2006; 23(7):569-76. DOI: 10.1111/j.1540-8175.2006.00278.x. View

13.

Katsi V, Georgiopoulos G, Oikonomou D, Aggeli C, Grassos C, Papadopoulos D . Aortic Stenosis, Aortic Regurgitation and Arterial Hypertension. Curr Vasc Pharmacol. 2018; 17(2):180-190. DOI: 10.2174/1570161116666180101165306. View

14.

Palmieri V, Bella J, Arnett D, Roman M, Oberman A, Kitzman D . Aortic root dilatation at sinuses of valsalva and aortic regurgitation in hypertensive and normotensive subjects: The Hypertension Genetic Epidemiology Network Study . Hypertension. 2001; 37(5):1229-35. DOI: 10.1161/01.hyp.37.5.1229. View

15.

Kim M, Roman M, Cavallini M, Schwartz J, Pickering T, Devereux R . Effect of hypertension on aortic root size and prevalence of aortic regurgitation. Hypertension. 1996; 28(1):47-52. DOI: 10.1161/01.hyp.28.1.47. View

16.

Chen X, Wang J, Lin X, Tang L, Yu W, Chen H . Diabetes mellitus: is it protective against aortic root dilatation?. Cardiology. 2008; 112(2):138-43. DOI: 10.1159/000142944. View

17.

Barth M, Selig J, Klose S, Schomakers A, Kiene L, Raschke S . Degenerative aortic valve disease and diabetes: Implications for a link between proteoglycans and diabetic disorders in the aortic valve. Diab Vasc Dis Res. 2018; 16(3):254-269. DOI: 10.1177/1479164118817922. View

18.

Hwang J, Kim D, Kim H, Kwak J, Cho S, Bae D . Impact of chronic kidney disease on clinical outcomes in patients with Stage B progressive aortic regurgitation (mild to moderate and moderate grades). Clin Cardiol. 2022; 45(4):391-400. PMC: 9019887. DOI: 10.1002/clc.23792. View

19.

Braun J, Kruger K, Manger B, Schneider M, Specker C, Trappe H . Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions. Dtsch Arztebl Int. 2017; 114(12):197-203. PMC: 5397890. DOI: 10.3238/arztebl.2017.0197. View

20.

Butt S, Jeppesen J, Torp-Pedersen C, Sam F, Gislason G, Jacobsen S . Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study. J Am Heart Assoc. 2019; 8(17):e013405. PMC: 6755829. DOI: 10.1161/JAHA.119.013405. View